Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibodies to watch in 2021
Hélène Kaplon, Janice M. Reichert
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 270

Showing 1-25 of 270 citing articles:

Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Zhiwen Fu, Shijun Li, Sifei Han, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 779
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 491
Emerging new therapeutic antibody derivatives for cancer treatment
Shijie Jin, Yanping Sun, Liang Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 301
Antibodies to watch in 2022
Hélène Kaplon, Alicia M. Chenoweth, Silvia Crescioli, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 292
Antibodies to watch in 2023
Hélène Kaplon, Silvia Crescioli, Alicia M. Chenoweth, et al.
mAbs (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 197
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 193
Observed Antibody Space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences
Tobias Hegelund Olsen, Fergus Boyles, Charlotte M. Deane
Protein Science (2021) Vol. 31, Iss. 1, pp. 141-146
Open Access | Times Cited: 176
Antibody structure prediction using interpretable deep learning
Jeffrey A. Ruffolo, Jeremias Sulam, Jeffrey J. Gray
Patterns (2021) Vol. 3, Iss. 2, pp. 100406-100406
Open Access | Times Cited: 156
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 136
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning
David Příhoda, Jad Maamary, Andrew B. Waight, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 102
Hybridoma technology; advancements, clinical significance, and future aspects
Sanchita Mitra, Pushpa C. Tomar
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 159-159
Open Access | Times Cited: 98
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Sachin S. Shivatare, Vidya S. Shivatare, Chi‐Huey Wong
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15603-15671
Open Access | Times Cited: 96
SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
Haolin Liu, Pengcheng Wei, John W. Kappler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 68
Therapeutics for COVID-19
Sima S. Toussi, Jennifer Hammond, Brian S. Gerstenberger, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 771-786
Open Access | Times Cited: 65
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
Janet M. Sasso, Rumiana Tenchov, Robert E. Bird, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 11, pp. 1951-2000
Open Access | Times Cited: 45
Moving towards an era of hybrid modelling: advantages and challenges of coupling mechanistic and data-driven models for upstream pharmaceutical bioprocesses
Apostolos Tsopanoglou, Ioscani Jiménez del Val
Current Opinion in Chemical Engineering (2021) Vol. 32, pp. 100691-100691
Open Access | Times Cited: 71
Antibody-based cancer therapy
Rebecca S. Goydel, Christoph Rader
Oncogene (2021) Vol. 40, Iss. 21, pp. 3655-3664
Open Access | Times Cited: 65
Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics
Rahul Khetan, Robin Curtis, Charlotte M. Deane, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 62
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Mehdi Arbabi‐Ghahroudi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5009-5009
Open Access | Times Cited: 57
Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery
Wiktoria Wilman, Sonia Wróbel, Weronika Bielska, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 57
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
Kristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 56
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 49
Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations
George Delidakis, Jin Eyun Kim, Katia George, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 249-274
Open Access | Times Cited: 47
Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy
Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Larissa Bueno Tofani, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 821-821
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top